EV Biologics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016	Jun '15 Jun 30, 2015	Jun '14 Jun 30, 2014
Net Income	-7.43	-53.19	8.68	10.69
Depreciation & Amortization	0.69	2.22	1.75	1.39
Asset Writedown & Restructuring Costs	1.91	52.69	-	-
Stock-Based Compensation	0.16	0.53	-	-
Provision & Write-off of Bad Debts	2	4.07	-	-0.13
Other Operating Activities	0.16	2.54	-0.33	-0.07
Change in Accounts Receivable	-1.35	-1.12	-4.09	-1.08
Change in Inventory	0.19	-0.24	0.11	-0.12
Change in Accounts Payable	0.62	0.13	-0.11	0.29
Change in Unearned Revenue	1.92	2.66	-0.4	0.38
Change in Income Taxes	-0.15	0.5	-0.02	0.14
Change in Other Net Operating Assets	2.82	2.5	0.61	0.62
Operating Cash Flow	1.55	13.28	6.2	12.11
Operating Cash Flow Growth	-88.33%	114.10%	-48.81%	6.64%
Capital Expenditures	-1.93	-36.62	-2.02	-0.84
Sale of Property, Plant & Equipment	-	0.02	-	-
Sale (Purchase) of Intangibles	-	-0	-0.01	-0.11
Other Investing Activities	-	-	0.03	2.6
Investing Cash Flow	-1.93	-36.6	-2	1.65
Short-Term Debt Issued	-	5.61	4.48	7.1
Long-Term Debt Issued	-	-	-	1.86
Total Debt Issued	-	5.61	4.48	8.96
Short-Term Debt Repaid	-0.45	-5.91	-10.84	-8.53
Long-Term Debt Repaid	-	-0.59	-1.23	-0.25
Total Debt Repaid	-0.45	-6.5	-12.07	-8.78
Net Debt Issued (Repaid)	-0.45	-0.89	-7.59	0.18
Issuance of Common Stock	-	14.06	-	-
Other Financing Activities	-	-2.55	-	-
Financing Cash Flow	-0.45	10.62	-7.59	0.18
Foreign Exchange Rate Adjustments	-0.09	-1.04	0.13	-0
Net Cash Flow	-0.92	-13.74	-3.26	13.94
Free Cash Flow	-0.38	-23.34	4.19	11.27
Free Cash Flow Growth	-	-	-62.87%	-
Free Cash Flow Margin	-3.99%	-54.74%	9.05%	25.35%
Free Cash Flow Per Share	-0.16	-9.79	2.62	7.04
Cash Interest Paid	-	0.2	1.07	1.22
Cash Income Tax Paid	0.55	2.6	3.2	3.18
Levered Free Cash Flow	1.15	-32.1	15.17	11.8
Unlevered Free Cash Flow	1.56	-31.46	15.98	12.54
Change in Working Capital	4.06	4.42	-3.9	0.24

Updated Nov 15, 2017. Source: S&P Global Market Intelligence. Standard template. Financial Sources.